A Jefferies analyst downgraded WellPoint Inc.’s stock, a day after the health insurer posted fourth-quarter results that missed Wall Street expectations.
Popular Posts:
- Ahead of the Bell: Endo Pharma share price rises
- Long legal fight ahead for health law
- Ahead of sale, Animal Health 3Q profit rises
- Ahead of the Bell: Ranbaxy enters Lipitor market
- Ahead of the Bell: Vivus shares fall